je.st
news
Tag: cancer
Wayne 6-year-old dies from brain cancer; girl's parents turn grief into gift for research
2015-04-08 05:28:37| Agriculture - Topix.net
Lily LaRue Anderson rests on her father Brian's shoulder after a fundraiser held in Garfield for four North Jersey sick children earlier this year. Lily LaRue Anderson loved animals, roller coasters, music, dancing, Disney and unicorns .
Tags: research
gift
turn
girls
Is WiFi a Government-Controlled Weapon That's Slowly Giving Us Cancer?
2015-04-04 01:12:44| Wireless - Topix.net
You are, in all likelihood, reading this post on a wireless internet-connected device-a computer, a phone, a tablet. Think about the last time you used a wired internet connection; now think about how long you've been slowly poisoning yourself with WiFi's ovary-killing, tumor-inducing radiation.
Hyundai Hope on Wheels awards more than $100 million for pediatric cancer
2015-04-03 19:43:16| Automakers - Topix.net
On April 2, Hyundai Motor America and its US dealers announced their latest donation to pediatric cancer research via their nonprofit organization, Hyundai Hope On WheelsA . This year, the program exceeds $100 million in lifetime funding to pediatric cancer research.
Tags: hope
million
awards
cancer
Therapure Innovations Receives FDA Approval To Proceed With A Phase 1 Clinical Trial Of The Targeted Liver Cancer Therapeutic TBI 302
2015-04-01 08:23:10| drugdiscoveryonline Home Page
Therapure Innovations, a division of Therapure Biopharma Inc., recently announces that the U.S. Food and Drug Administration (FDA) has given the company approval to proceed with a Phase 1 clinical trial of TBI 302, a targeted therapeutic for the treatment of liver cancer
Tags: trial
phase
approval
cancer
Syndax and Merck to Collaborate on Immuno-Oncology Study Evaluating Entinostat in Combination with KEYTRUDA (pembrolizumab) in Lung Cancer and Melanoma
2015-03-31 14:00:00| Merck.com - Product News
Dateline City: WALTHAM, Mass. & KENILWORTH, N.J. WALTHAM, Mass. & KENILWORTH, N.J.--(BUSINESS WIRE)--Syndax Pharmaceuticals, Inc., and Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that they have entered into a clinical trial collaboration to evaluate the safety and efficacy of combining Syndaxs entinostat, an investigational epigenetic therapy, with Mercks KEYTRUDA (pembrolizumab), the first anti-PD-1 therapy approved in the United States. Language: English Contact: Merck Media Relations:Pamela Eisele, 267-305-3558Claire Mulhearn, 908-236-1118orMerck Investor Relations:Justin Holko, 908-740-1879orSyndax Corporate:Bob Goodenow, 781-419-1418Chief Business Officerbgoodenow@syndax.com Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: study
combination
cancer
evaluating
Sites : [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] next »